Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

The key differences between Dexcom and FreeStyle Libre include sensor characteristics, frequency of readings, minimum age of use, and types of alerts and alarms. This article explains what CGMs ...

Dexcom has submitted an application for the 15-day sensor to the Food and Drug Administration for clearance. Using technology to manage Type 2 diabetes was also a focus at the conference.

Dexcom has submitted the 15-day G7 sensor to the FDA for clearance and anticipates ... You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Cardinal Health’s ...

1. Dexcom previews new data for 15-day glucose monitor Dexcom shared the first data for its 15-day continuous glucose monitor ...

1. Stelo CGM Launch: In August 2024, DexCom announced the commercial launch of Stelo CGM, the first over-the-counter glucose sensor in the U.S. for non-insulin using Type 2 diabetes and ...

1. Stelo CGM Launch: In August 2024, DexCom announced the commercial launch of Stelo CGM, the first over-the-counter glucose sensor in the U.S. for non-insulin using Type 2 diabetes and prediabetes ...

1 showing an overall mean absolute relative difference (MARD) of 8.0%, making it the most accurate CGM sensor.2 New Dexcom G7 automated insulin delivery and smart insulin pen integrations also ...